The next wave of hepatitis C virus: The epidemic of intravenous drug use

@article{Shiffman2018TheNW,
  title={The next wave of hepatitis C virus: The epidemic of intravenous drug use},
  author={Mitchell L Shiffman},
  journal={Liver International},
  year={2018},
  volume={38},
  pages={34 - 39}
}
  • M. Shiffman
  • Published 1 February 2018
  • Medicine
  • Liver International
The epidemic of hepatitis C virus (HCV) began in the 1960s when transmission was primarily the result of blood transfusions. By 1990, when HCV was identified and a serologic test for screening donated blood was implemented, 123 million persons had already become infected worldwide and HCV was the most common cause of cirrhosis, hepatocellular carcinoma and the most common indication for liver transplantation. Approximately 75% of persons with HCV are “baby boomers” born between the years 1945… 
Update on Hepatitis C Epidemiology: Unaware and Untreated Infected Population Could Be the Key to Elimination
TLDR
To achieve HCV elimination, health programmes should include improvement to access to health care services, increased screening and new projects to identify a submerged portion of patients with HCV infection.
Hepatitis C Virus Envelope Glycoproteins: A Balancing Act of Order and Disorder
TLDR
The structural complexities of HCV E1 and E2 are discussed, and it is suggested that structural flexibility may play a role in shielding antigenic epitopes during infection.
Treatment of early stage chronic hepatitis C virus infection
TLDR
This review evaluates the aspects underlying the benefit of treating chronic HCV infection at the early stage of disease and outlines the considerations that have to be taken into account when planning treatment in patients with HCV and minimal liver disease.
Hepatitis B and C.
TLDR
The epidemiology, virology, immunobiology, prevention, clinical manifestations, evaluation, and the advances in treatment of hepatitis B and C in children are discussed.
Trends of recent hepatitis C virus infection among HIV-positive men who have sex with men in Taiwan, 2011–2018
TLDR
An expanding HCV epidemic among HIV-positive men who have sex with men (MSM) is occurring in Taiwan and improving access to HCV testing and early linkage to treatment are needed to curb the expandingHCV epidemic.
Hepatitis C Virus Structure: Defined by What It Is Not.
TLDR
This review will focus on structural progress on HCV virion, core protein, envelope glycoproteins, and specific host receptors.
Epidemiology and treatment status of hepatitis C virus infection among people who have ever injected drugs in Korea: a prospective multicenter cohort study from 2007 to 2019 in comparison with non-PWID
TLDR
The epidemiological characteristics, but not treatment uptake and outcomes, were different between the PWID and non-PWID groups, and active HCV screening and treatment should be offered to PWID in Korea.
Chronic Hepatitis B Virus in Patients with Chronic Hepatitis C Virus.
TLDR
Patients with hepatitis B surface antigen are at the highest risk for reactivation, and these patients should receive prophylactic treatment of HBV during and for 6 months after HCV treatment.
Hepatitis C virus infection mortality trends according to three definitions with special concern for the baby boomer birth cohort
We examined mortality trends of hepatitis C virus (HCV) infection in the United States in 1999‐2018 according to the following definitions: HCV as the underlying cause of death (UCOD), HCV mentioned
Expanding Capacity to Treat Hepatitis C: Overcoming Barriers and New Innovations
TLDR
The critical role of expanding treatment capacity to enhance these efforts through a multifaceted strategy which incorporates education, training, and multidisciplinary support across clinical settings such as specialty centers, primary care, community health centers, methadone and substance use programs, prisons, and pharmacy-based clinics is discussed.
...
1
2
3
...

References

SHOWING 1-10 OF 68 REFERENCES
The epidemiology of acute and chronic hepatitis C.
  • M. Alter
  • Medicine
    Clinics in liver disease
  • 1997
TLDR
Physicians and other health care professionals need to be educated not only about the appropriate medical management of HCV infected patients, but also about the known and potential risks for HCV infection, the need to ascertain complete risk behavior histories from their patients, the appropriate evaluation of high-risk patients for evidence of infections, and the recommendations for prevention.
Hepatitis C virus infection among adolescents and young adults:Massachusetts, 2002-2009.
  • Medicine
    MMWR. Morbidity and mortality weekly report
  • 2011
TLDR
Results of both efforts revealed continued increases in rates of newly reported HCV infection among persons aged 15--24 years, and injection drug use (IDU) was the most common risk factor for HCV transmission.
Chronic Hepatitis C Virus Infection in the United States, National Health and Nutrition Examination Survey 2003 to 2010
TLDR
The estimated prevalence of chronic HCV infection in the United States has decreased and risk factors for infection are essentially unchanged from previous periods and were reported by only about one half of infected persons.
The past incidence of hepatitis C virus infection: Implications for the future burden of chronic liver disease in the United States
TLDR
Past incidence of acute HCV infection was estimated using national seroprevalence data and relative age‐specific incidence data from a sentinel counties surveillance system and showed a large increase in the incidence from the late 1960s to the early 1980s.
45-Year Follow-up of Hepatitis C Virus Infection in Healthy Young Adults
TLDR
Through access to frozen serum specimens obtained during the late 1940s and early 1950s from more than 9000 healthy young persons, a retrospective cohort study was able to determine liver-related morbidity and mortality in HCV-positive andHCV-negative persons.
Aging of hepatitis C virus (HCV)-infected persons in the United States: a multiple cohort model of HCV prevalence and disease progression.
TLDR
Prevalence of hepatitis C cirrhosis and its complications will continue to increase through the next decade and will mostly affect those older than 60 years of age, but wider application of antiviral treatment and better responses with new agents could significantly reduce the impact of this disease in coming years.
Characteristics of patients with dual infection by hepatitis B and C viruses.
TLDR
It is suggested that HBV DNA replication inhibits HCV RNA replication in patients with chronic active hepatitis B and C but increases the severity of histological lesions.
Transmission of hepatitis C virus among people who inject drugs: viral stability and association with drug preparation equipment.
TLDR
The potential risk of HCV Transmission among injection drug users who share water, filters, and water containers is demonstrated and will help to define public health interventions to reduce HCV transmission.
Hepatitis C virus testing of persons born during 1945-1965: recommendations from the Centers for Disease Control and Prevention.
TLDR
These evidence-based recommendations to increase the proportion of hepatitis C virus-infected persons who know their status and are linked to appropriate care and treatment and address brief alcohol screening, as alcohol accelerates progression of liver disease among HCV- Infected individuals.
Evidence of continued injecting drug use after attaining sustained treatment-induced clearance of the hepatitis C virus: Implications for reinfection.
TLDR
Evidence of continued injecting drug use among PWID following successful treatment for HCV and attainment of a sustained viral response (SVR) indicates that an increasing significant minority of PWID continue to inject post-SVR at an intensity which leads to either hospitalisation or death and increased risk of reinfection.
...
1
2
3
4
5
...